Alpine Global Management’s Aclaris Therapeutics ACRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-30,680
| Closed | -$76.1K | – | 135 |
|
|
2024
Q4 | $76.1K | Buy |
+30,680
| New | +$76.1K | 0.01% | 195 |
|
|
2024
Q3 | – | Sell |
-177,909
| Closed | -$196K | – | 164 |
|
|
2024
Q2 | $196K | Buy |
+177,909
| New | +$196K | 0.03% | 311 |
|
|
2022
Q1 | – | Sell |
-20,528
| Closed | -$298K | – | 434 |
|
|
2021
Q4 | $298K | Buy |
+20,528
| New | +$298K | 0.04% | 437 |
|
|
2021
Q1 | – | Sell |
-22,333
| Closed | -$144K | – | 307 |
|
|
2020
Q4 | $144K | Buy |
+22,333
| New | +$144K | 0.03% | 142 |
|